TITLE

THE ROLE OF ACTIVE EFFLUX IN ANTIBIOTIC-RESISTANCE OF CLINICAL ISOLATES OF HELICOBACTER PYLORI

AUTHOR(S)
Falsafi, T.; Ehsani, A.; Niknam, V.
PUB. DATE
October 2009
SOURCE
Indian Journal of Medical Microbiology;Oct2009, Vol. 27 Issue 4, p335
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Purpose: In gram-negative bacteria, active efflux pumps that excrete drugs can confer resistance to antibiotics however, in Helicobacter pylori this role is not well established. The purpose of this study is to evaluate the role of active efflux in resistance of H. pylori isolates to antibiotics. Materials and Methods: Twelve multiple antibiotic resistant (MAR) isolates resistant to at least four antibiotics, including β-lactams, metronidazole, tetracycline, erythromycin, and ciprofloxacin; three resistant to only β-lactams, and two hyper-susceptible isolates, were obtained from screening of 96 clinical isolates of H. pylori. Their minimal inhibitory concentrations (MICs) for antibiotics and ethidium-bromide (EtBr) were compared in the presence- and absence of a proton-conductor, carbonyl cyanide-m chlorophenyl-hydrazone (CCCP) using agar-dilution and disc diffusion. Drug accumulation studies for EtBr and antibiotics were assessed in the presence and absence of CCCP using spectrofluorometry. Results: MIC of EtBr for eight MAR-isolates was decreased two- to four-folds in the presence of CCCP, of which five showed reduced MICs for β-lactam, metronidazole, tetracycline, and ciprofloxacin with CCCP. Accumulation of EtBr by the MAR-isolates was rapid and not dependant on the pattern of multiple resistance. Antibiotic accumulation assay confirmed the presence of energy-dependant efflux of β-lactam, metronidazole, tetracycline, and ciprofloxacin, but no erythromycin in five MAR isolates. Energy-dependant efflux of EtBr or antibiotics was not observed for four MAR-isolates, and three isolates were resistant only to β-lactams. Conclusion: Energy-dependant efflux plays a role in the resistance of H. pylori clinical isolates to structurally unrelated antibiotics in a broadly specific multidrug efflux manner. Difference in the efflux potential of MAR isolates may be related to the presence or absence of functional efflux-pumps in diverse H. pylori isolates.
ACCESSION #
44320253

 

Related Articles

  • Efflux pump gene hefA of Helicobacter pylori plays an important role in multidrug resistance. Zhi-Qiang Liu; Peng-Yuan Zheng; Ping-Chang Yang; Shimoyama, Tadashi // World Journal of Gastroenterology;9/7/2008, Vol. 14 Issue 33, p5217 

    AIM: To determine whether efflux systems contribute to multidrug resistance of H pylori. METHODS: A chloramphenicol-induced multidrug resistance model of six susceptible H pylori strains (5 isolates and H pylori NCTC11637) was developed. Multidrug-resistant (MDR) strains were selected and the...

  • Evolution of resistance to clarithromycin and metronidazole in Helicobacter pylori Spanish clinical isolates. Lopez-Brea, M.; Domingo, D.; Villar, H.; Martinez, M.J.; Hernandet, J.M.; Alarcon, T. // Gut;Sep2002 Supplement 2, Vol. 51, pA2 

    The aim of this study was to determine the in vitro susceptibility of amoxicillin, tetracycline, clarithromycin and metronidazole in Spanish H. pylori strains from 1994 to 2002. Material and methods: A total of 770 H. pylori strains were studied from patients attended in Hospital San Agustin,...

  • Phenotypic and Genetic Characterization of Antimicrobial Profiles of Helicobacter pylori Strains in Cuba. Llanes, Rafael; Soria, Claudia; Nagashima, Shigeo; Kobayashi, Nobumichi; Gala, Angela; Guzmán, Daymi; Feliciano, Onelkis; Valdés, Lidunka; Gutiérrez, Oderay; Fernández, Heriberto; Llop, Alina; Wada, Akihiro // Journal of Health, Population & Nutrition;Apr2010, Vol. 28 Issue 2, p124 

    The study evaluated the antibiotic resistance patterns of Helicobacter pylori strains against metronidazole and clarithromycin in a hospital in Havana, Cuba. Eighty-five percent, 22.5%, and 10% of 40 H. pylori strains investigated were resistant to metronidazole, ciprofloxacin, and...

  • "Rescue" regimens after Helicobacter pylori treatment failure. Gisbert, Javier P.; Yamaoka, Yoshio; Shimoyama, Tadashi // World Journal of Gastroenterology;9/21/2009, Vol. 14 Issue 35, p5385 

    Helicobacter pylori (H pylori) infection is the main cause of gastritis, gastroduodenal ulcer disease, and gastric cancer. After more than 20 years of experience in Hpylori treatment, in my opinion, the ideal regimen to treat this infection is still to be found. Currently, apart from having to...

  • H PYLORI ANTIBIOTIC RESISTANCE: PREVALENCE, IMPORTANCE, AND ADVANCES IN TESTING. Mégraud, F. // Gut;Sep2004, Vol. 53 Issue 9, p1374 

    The article focuses on the prevalence of helicobacter pylori resistance to various antibiotics, their clinical importance and methods of testing, especially in light of the resistance mechanism which allows application of molecular methods. The prevalence of helicobacter pylori resistance to...

  • Increase in Resistance Rates of H.pylori Isolates to Metronidazole and Tetracycline-Comparison of Three 3-Year Studies. Siavoshi, Farideh; Saniee, Parastoo; Lati-Navid, Saeid; Massarrat, Sadegh; Sheykholeslami, Arghavan // Archives of Iranian Medicine (AIM);May2010, Vol. 13 Issue 3, p177 

    Antimicrobials have been useful in the treatment of H.pylori-related dyspeptic diseases. However, emergence of resistant strains often decreases the eradication rates of H.pylori infections. Large-scale use of antimicrobials will lead to the diminishment of susceptible strains while allowing...

  • Randomized Controlled Trial Comparing Proton Pump Inhibitor-Based Eradication Regimen versus Low-Cost Eradication Regimen for Patients with Helicobacter pylori with Uninvestigated Dyspepsia. Chen, Yang K.; Jajodia, Prahalad; DeGuzman, Lino; Khan, Shahid A.; Jakribettuu, Vaman S. // Journal of Applied Research;2006, Vol. 6 Issue 3, p214 

    Background: The impact of various Helicobacter pylori eradication regimens in patients with uninvestigated dyspepsia is controversial. Objective: To compare symptom relief, tolerability and treatment compliance among H pylori-positive subjects with uninvestigated ulcer-like dyspepsia treated...

  • A Single Drug for Helicobacter pylori Infection: First Results With a New Bismuth Triple Monocapsule. de Boer, Wink A.; van Etten, Ruud J. X. M.; Schneeberger, Peter M.; Tytgat, Guido N. J. // American Journal of Gastroenterology;Mar2000, Vol. 95 Issue 3, p641 

    OBJECTIVE: In this pilot study we investigated the efficacy and tolerability of a new monocapsule that contains a bismuth compound, tetracycline, and metronidazole. If proven to be effective, this monotherapy would turn the well-accepted multidrug regimen of standard bismuth-based triple therapy...

  • Helicobacter pylori in Iran: A systematic review on the antibiotic resistance. Khademi, Farzad; Poursina, Farkhondeh; Hosseini, Elham; Akbari, Mojtaba; Safaei, Hajieh Ghasemian // Iranian Journal of Basic Medical Sciences;Jan2015, Vol. 18 Issue 1, p2 

    Objective(s): Helicobacter pylori (H. pylori) is a pathogenic bacterium that colonizes the stomachs of approximately 50% of the world's population. Resistance of H. pylori to antibiotics is considered as the main reason for the failure to eradicate this bacterium. The aim of this study was to...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics